Thread regarding CVS layoffs

CVS Accused of Massive Dr-g Price Manipulation Scheme in Bombshell FTC Report

I’m sure this comes as no surprise to those who work here. Sad if true and so unethical. surely it doesn’t line up to their “values”. Oh that’s right, they have no ethical values.

https://upriseri.com/cvs-accused-of-massive-dr-g-price-manipulation-scheme-in-bombshell-ftc-report/

by
| 1054 views | | 6 replies (last July 18, 2024) | Reply
Post ID: @OP+1tyKCSWU

6 replies (most recent on top)

Don't they watch their own Fraud and Abuse classes that they shove down our throats?

by
| | Reply
Post ID: @1cgw+1tyKCSWU

Corporate "pigs". Make them pay...seize their assets.

by
| | Reply
Post ID: @1mmu+1tyKCSWU

Isn't this just the pricing model where cheap generic medications are used to subsidize the more expensive medications?

by
| | Reply
Post ID: @1xuc+1tyKCSWU

One of the most alarming findings in the report concerns the pricing of specialty dr-gs, particularly generic versions of cancer medications. The FTC’s analysis found that PBM-affiliated pharmacies, including those owned by CVS, were often reimbursed at rates 20 to 40 times higher than the National Average Dr-g Acquisition Cost (NADAC) for these medications. For example, commercial health plans reimbursed affiliated pharmacies for generic Zytiga, used to treat prostate cancer, at more than $5,800 per month in 2022 – approximately 25 times the $229 acquisition cost reflected by NADAC.

by
| | Reply
Post ID: @1uil+1tyKCSWU

How many times do I have to say this? This is typical CVS doing shady stuff. No one should be surprised at this.

by
| | Reply
Post ID: @1zbb+1tyKCSWU

Lol that's just the beginning. You can add on securities fraud to the list. Incoming lawsuits from lord knows how many firms representing shareholders.

Between that and the incoming FTC lawsuit legal is going to be very very busy.

Have fun answering to Congress, dummies. Hopefully they can fit all that pompous incompetence into one building.

by
| | Reply
Post ID: @1gzu+1tyKCSWU

Post a reply

: